Предыдущая страница реферата | 1  2  3  4  5  6  7  8  9  10 | Следующая страница реферата

Denis P. Perineal descent at defecography in women with straining at stool: a lack of specificity or predictive value for future anal incontinence? Eur J Gastroenterol Hepatol 1995:7:75-79.
109. Berman IR, Manning DH, Harris MS, Streamlining the management of defecation disorders. Dis Colon Rectum, 1990, 33(9), 778-85.
110. Binder HJ, Cummings J, Soergel K. edit. Short chain fatty acids/ Falk

Symposium 73; Kluwer Academic Publishers, 1994, p.236.
111. Bjelke E. Epidemiologie studies of cancer of the stomach, colon and rectum. Scand I Gastroenterol 9(Suppl):31, 1974.
112. Bleijenberg G, Kuijpers HC. Treatment of the spastic pelvic floor syndrome with biofeedback. Dis Colon Rectum 1987,36:108-11.
113. Bouchoucha M, Devroede G, Arhan P, Strom B, Weber J, Cugnenc P-H,

Denis P, Barbier J-P. What is the meaning of colorectal transit time measurement? Dis Colon Rectum 1992;35:773-782.
114. Bour H: Fibres Alimentaires et constipation // Rev. Franc.

Gastroenterol.- 1984.- No.197.-p. 114-119.
115. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999;44:682-686.
116. Bouras EP, Camilleri M, Burton DD, Thomforde G. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without rectal evacuation disorder. Gastroenterology

2001;120:652-668.
117. Browning SM: Constipation, diarrhea, and irritable bowel syndrome.

Primary Care; Clinics in Office Practice, vol.26, N.2, March 1999.
118. Bruckschen E, Horosiewicz H. Chronische Obstipation. Vergleich von mikrobiologischer Therapie und Lactulose. Mьnch Med Woschenschr.

1994;136:241-5.
119. Burleigh DE. Evidence for a functional cholinergic deficit in human colonic tissue resected for constipation. J Pharm Pharmacol, 40:55-7,

1988 Jan
120. Camilleri M, Choi M-G. Review article: irritable bowel syndrome.

Aliment Pharmacol Ther 1997; 11: 3-15.
121. Camilleri M. Management of the irritable bowel syndrome.

Gastroenterology 2001;120:652-668.
122. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984;25:165-173.
123. Celik AF, Tomlin J, Read NW. The effect of oral vancomycin on chronic idiopathic constipation. Aliment Pharmacol Ther. 1995;9:63-8.
124. Chadwick VS et Phillips SF. // Gastroenterology, 1982, v.2.
125. Chaussade S, Roche H, Khyardi A, et al. A new method for measuring colonic transit time. Description and validation. Gastroenterol Clin

Biol 1986;10:385-389.
126. Chaussade S. Determination of total and segmental colonic transit time in constipated patients. Results in 91 patients with a new simplified method. Dig Dis Sci 34:1168-1172, 1989 Aug.
127. Chiotakakou-Faliakou E; Kamm MA; Roy AJ; Storrie JB; Turner IC.

Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut, 42(4):517-21 1998 Apr.
128. Chong-Liang HE, Burghardt L, Wang L, Pemberton J et al. Decreased intestinal cell of Cojal volume in patients with slow-transit constipation. Gastroenterology, 2000;118:14-21.
129. Connell AM, Hilton C, Irvine G, et al. Variation in bowel habit in two population samples. Br Med J 1965;2:1095.
130. Corazziari E, Badiali D, Bazzocchi G, Bassotti G, Roselli P,

Mastropaolo G et al. Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000;46:522-526 (April)
131. Coremans G, Kerstens R, Woods M. Dose-ranging efficacy, safety and tolerability of prucalopride in patients with chronic constipation:

Results of two randomized, placebo-controlled, double-blind trials. Am

J Gastroenterol 1999;94(9):2669 (Abstract).
132. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N,

Cedarbaum JM. Recombinant Human Neurotrophic Factors Accelerate

Colonic Transit and Relieve Constipation in Humans. Gastroenterology

2000;119:41-50.
133. Couturier D. Comparative study of Forlax and Transipeg in the treatment of functional constipation in the adult. Ann Gastroenterol

Hepatol (Paris), 1996 May-Jun, 32:135-40.
134. Cremerius J. Die Prognose funktioneller Syndrome.- Leipzig, 1968, s.134.
135. Сummings J., Kelly M.J., Smith C.L.: The significance of propulsive, retropulsive and segmenting contractions of the colon and rectum in the irritable bowel syndrome // Gut.- 1983.- Vol.24.- P.368-368.
136. Cummings JH. Quantitating short chain fatty acid production in humans.

In: Short chain fatty acids/ Falk Symposium 73; Kluwer Academic

Publishers, 1994, 11-19.
137. Davies GJ, Crowder M, Reid B, Dickerson JWT. Bowel function measurements of individuals with different eating patterns. Gut

1986;27:164.
138. de Graaf EJ; Gilberts EC; Schouten WR. Role of segmental colonic transit time studies to select patients with slow transit constipation for partial left-sided or subtotal colectomy. Br J Surg, 83(5):648-51

1996 May
139. Delvaux M, Frexinos J. A European approach to irritable bowel syndrome management. Can J Gastroenterol 1999 Mar;13 Suppl A:85A-88A.
140. Devroede G. Constipation. In: Sleisenger MH, Fordtran JS, eds.

Gastrointestinal disease: pathophysiology, diagnosis and management.

4th ed. Philadelphia: WB Saunders, 1989:331.
141. Diamant NE, Kamm MA, Wald A, et al. American Gastroenterologic

Рекомендуем скачать другие рефераты по теме: контрольная работа 9, курсовики скачать бесплатно.





Предыдущая страница реферата | 1  2  3  4  5  6  7  8  9  10 | Следующая страница реферата